We are live on !
Find out more
K5 Global Advisor Portfolio holdings
AUM
$4.02B
Turnover
50%
This Fund
S&P 500
This Quarter Est. Return
-11.7%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.02B
AUM Growth
-$2.56B
(-39%)
Cap. Flow
-$1.65B
Cap. Flow % of AUM
Cap. Flow %
-41%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
1
Closed
1
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Neutron Holdings
LIME
|
+$306K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$1.65B |
| 2 |
Vicarious Surgical
RBOT
|
+$5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 99.99% |
| 2 | Consumer Staples | 0.01% |
| 3 | Healthcare | 0% |
Similar funds
K5 Global Advisor's Q3 2026 Portfolio in Review
As of Q3 2026, K5 Global Advisor held 4 positions worth $4.02B, down 39% from $6.59B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
K5 Global Advisor withdrew a net $1.65B in Q3 2026, closing 1 position and reducing 1 holding. Its most notable exit was Vicarious Surgical, an estimated $5K position sold in full.
By sector, the portfolio is most concentrated in Industrials at 100% of assets, down from 100% a quarter earlier, followed by Consumer Staples and Healthcare.
Against the trend, K5 Global Advisor opened a new position in Neutron Holdings worth $267K.
- K5 Global Advisor's largest Q3 2026 buy was Neutron Holdings: 9,494 shares worth $267K.
- K5 Global Advisor's biggest Q3 2026 reduction was SpaceX, cutting an estimated $1.65B.
- K5 Global Advisor fully exited Vicarious Surgical in Q3 2026, selling an estimated $5K.
- K5 Global Advisor's ten largest holdings make up 100% of its $4.02B portfolio in Q3 2026.
- K5 Global Advisor opened 1 new position and closed 1 in Q3 2026.
- K5 Global Advisor's portfolio value fell 39% quarter-over-quarter to $4.02B.
Based on K5 Global Advisor's 13F filing for Q3 2026, filed 20 Oct 2026.